VYNE Therapeutics Inc. ( VYNE) - Stock Earnings
Stock symbol VYNE is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker VYNE was renamed to
YARW
effective 2026-07-28.
VYNE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.3 million USD | 169000 USD |
| 2025Q4 | -4.8 million USD | 130000 USD |
| 2026Q1 | -3.6 million USD | 86000 USD |
| 2026Q4 Est. | — | — |
VYNE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.5 million USD | 424000 USD |
| 2024 | -39.8 million USD | 501000 USD |
| 2025 | -26.5 million USD | 570000 USD |
| 2026 Est. | — | — |
VYNE
Price: $28.56
52 week price:
Earnings Per Share: -0.51 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 68900
Market Capitalization: 11.3 million